Our #1 Biotech Stock for October

Big Pharma loves to buy small biotech's right after the market drops.

When the market dropped 19% in the fourth quarter of 2018, Ex-Wall Street CEO Dylan Jovine picked 3 biotech stocks ripe for a takeover.

On October 1st, 2018, he recommended Tesaro… 63 days later it was taken over for an easy 91% profit…

On October 19, 2018, he recommended Pacific Biosciences… 4 days later it was taken over for a quick 72% gain…

On January 4, 2019, he recommended Loxo Oncology… 3 days later it was taken over for a fast 71% gain…

Well, guess what? The Coronavirus market drop has given Big Pharma its first takeover target of 2020.

In this special letter, you'll learn why Dylan thinks now is the best time to make money with this tiny stock.

You'll discover:

  • Why Big Pharma firms Allergan, Celgene and others have invested over $1 billion into this tiny biotech.
  • Why President Trump thinks this biotech's breakthrough is a matter of national security.
  • How a takeover could make you $41,250 in profits any day now.

That's because in this letter, we'll show you how to get into this company right now – before it's too late!

You don't want to miss this.

Read this urgent letter now >>>


Brad Sullivan
Behind the Markets